Skip to content

Author

G. Limongelli

We have 3 of 93 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-world comparison of contemporary diagnostic criteria for cardiac sarcoidosis: a three-year experience at a tertiary referral center

Sarcoidosis is a chronic systemic inflammatory disease of unknown aetiology characterized by non-caseating epithelioid granulomas. Although it most commonly presents with hilar lymphadenopathy or pulmonary infiltration, clinically overt cardiac involvement occurs in approximately 5% of cases and is associated with an...

S. Montuoro, E. Monda, E. Bobbio et al. · 0 citations
Review Open access Oct 2026

Tracking Active Fibroblast-Mediated Tissue Remodelling in Cardiomyopathies: Translational Insights from FAPI PET Imaging

Myocardial fibrosis is a major pathological component of cardiac remodelling and contributes to ventricular stiffness, impaired myocardial function, heart failure progression, and arrhythmic vulnerability across a broad spectrum of cardiomyopathies. In hypertrophic cardiomyopathy (HCM), fibrotic remodelling encompasses...

I. Fortuna, Janete Santos, P. Soeiro et al. · 0 citations
Open access Aug 2026

Pattern of use of conventional medical treatments of heart failure with reduced ejection fraction in end-stage hypertrophic cardiomyopathy.

While BB and RASi are commonly used in ES-HCM, MRA and SGLT2i are prescribed less frequently and in patients with a worse clinical profile, suggesting both clinical inertia and limitations inherent to the disease pathophysiology.

G. Tini, Isabella Perlati, S. Palma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.